8
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous Article

Literature Alerts

Pages 793-805 | Published online: 26 Jun 2009

LITERATURE ALERTS

  • %99mTechnetium-stannous oxinate as marker of liposome formulations. ALAFANDY, M., GOFFINET, G., UMBRAIN, V., D'HAESE, J., CAMU, F., and LEGROS, F. J., Nucl. Med. Biol. 1996, 23 (7), 881–887.
  • A study on the anticancerous characteristics of the targeted liposomes containing linoeic platinum. SUN, R., ZHANG, J., and WANG, Y., Shengtou Wuli Xuebao, 1996, 12 (3), 419–427.
  • A synthetic peptide representing residues 7 to 21 of human luteinizing hormone beta-subunit binds calcium, facilitates calcium uptake by liposomes and possesses sequence similarity to calcium binding domains of calmodulin. GRASSO, P., Regul. Pept. 1996,65 (2), 109–114.
  • A genetib system for Archaea of the genus Methanosarcina: liposome-mediated transforma-tion and construction of shuttle vectors. METCALF, W. W., ZHANG, J. K., APOLINARIO, E., SOWERS, K. R., WOI.FE, R. S., Proc. Natl. Acad. Sci. USA. 1997, 94 (6), 2626–2631.
  • A model for the initiation and growth of extracellular lipid liposomes in arterial intima. YIN, Y., Lim, K. H., WEINBAUM, S., CHIEN, S., and RUMSCHITZKI, D. S., Am. y. Physiol., 1997, 272 (2 Pt 2), H1033–H1046.
  • A parametric study of microencapsulation approach to the preparation of polystyrene shells. AI.FONSO, E. L., CliEN, S. H., WITTMAN, M. D., PAPERNOV, S., and HARDING, D., Polymer, 1997, 38 (7), 1639–1646.
  • A rat extremity soft tissue sarcoma model for the study of systemic treatment with Stealth liposome-encapsulated tumor necrosis factor-.alpha. and cytotoxic agents. TEN HAGEN, T. L. M., EGGERMONT, A. M. M., Adv. Drug Delivery Rev., 1997, 24 (2.3), 245–256.
  • A rigorous theory of remote loading of drugs into liposomes: transmembrane potential and induced pH-gradient loading and leakage of liposomes. CE1-1, B., and LASIC, D. D., J. Colloid Interface Sci., 1997, 185 (1), 9–18.
  • A study of synthesis and properties of pressure-sensitive color-developing microcapsules. QIAN, L., and CHEN, S., Zhongguo Fangzhi Dazue Xuebao, 1996, 22 (5), 1–8.
  • A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphoter-icin B formulation. ALAK, A., MO', S., and BEKERSKY, I., Ther. Drug Monit., 1996, 18(5), 604–609.
  • A new dyeing method without a water medium using microcapsules. SAWANOI, Y., SHIMRO, Y., YAMAMOTO, T., and Kimizu, M., lshikawa-ken Kogyo Shikenjo Kenkyu Hokoku, 1996, 45, 41–46.
  • Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). PARR, M. J., MASIN, D., CuLus, P. R., and BALLY, M. B., J. Pharmacol. Exp. Ther., 1997, 280 (3), 1319–1327.
  • Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. YARDLEY, V., and CROFT, S. L., Antimicrob. Agents Chemother., 1997, 41(4), 752–756.
  • Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. SHARMA, A., MAYHEW, E., BOLCSAK, L., CAVANAUGH, C., HARMON, P., JANOFF, A., and BERNACKI, R. J., Int. J. Cancer, 1997, 71(1), 103–107.
  • Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation. CRorrs, G., SAD, H., and PARK, T. G., J. Controlled Release, 1997, 47 (1), 101–111.
  • An experimental study on lowered toxicities of adriamycin with liposome encapsulation in mice. FAN, J., YANG, D., and WEND, G., Zhongguo Yaoxue Zazhi ( Beijing), 1996, 31 (11), 655–658.
  • Anti-inflammatory activity of ethyl cellulose microcapsules of diclofenac sodium in rats. RANI, S., HIREMATH, R., and PRAKASAM, K., Indian Drugs, 1996, 33 (12), 615–616.
  • Antibody-targeted liposomes: prospects and problems. ALLEN, T. M., HANSEN, C. B., KAO, G. Y., MA, J., MARIAN, J. M. J., DE MENEZES, D. L., MOASE, E. H., Q1, W., and STUART, D., Adv. Drug Delivery Rev., 1997, 24(2,3), 243.
  • Antioxidant actions of .beta.-carotene in liposomal and microsomal membranes: role of carotenoid-membrane incorporation and .alpha.-tocopherol. LIEBLER, D. C., STRATTON, S. P., and KAYSEN, K. L., Arch. Biochem. Biophys., 1997, 338 (2), 244–250.
  • Antisense inhibition of angiotensinogen in hepatoma cell culture is enhanced by cationic liposome delivery. WIELBO, D., Siii, N., and SERNIA, C., Biochem. Biophys. Res. Commun., 1997, 232 (3), 794–799.
  • Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. FRESTA, M., and Puraisi, G., J. Drug Target, 4 (2), 95–101.
  • Application of alginate gel as a vehicle for liposomes. II. Erosion of alginate gel beads and the release of loaded liposomes. TAKAGI, I., NAKASHIMA, H., TAKAGI, M., YOTSUYANAGI, T., and IKEDA, K., Chem. Pharm. Bull. (Tokyo), 1997, 45 (2), 389–393.
  • Application of liposomes for cancer metastasis. OKU, N., KOIKE, C., TOKUDOME, Y., OKADA, S., NISHIKAWA, N., TSUKADA, H., Kiso, M., HASEGAWA, A., FUJII, H., MURATA, J., and SAIK/, 1., Adv. Drug Delivery Rev., 1997, 24 (2,3), 215–223.
  • Application of liposomes to the treatment of liver metastasis. KONNO, H., MAURO, Y., MATSUDA, I., TANAKA, T., BABA, S., Adv. Drug Delivery Rev., 1997, 24 (3,2), 331–335.
  • Bacteriophage and microsphere transport in saturated porous media: forced-gradient experi-ment at Borden, Ontario. BALES, R. C., Li, S., YEH, T. C. J., LENCZEWSKI, M. E., GERRA, C. P., Water Resour. Res., 1997, 33 (4), 639–648.
  • Beneficial effect of nebracetam on energy metabolism after microsphere-induced embolism in rat brain. TAKEO, S., MIYAKE, K., TANONAKA, K., TAKAGI, N., TAKAGI, K., KISHIMOTO, K., SUZUKI, M., KATSURAGI, A., GOTO, M., and OSHIKAWA, S., Arch. Int. Pharmacodyn. Ther., 1996, 331 (3), 232–245.
  • Biliary excretion of polystyrene microspheres with covalently linked FITC fluoroscence after oral and parenteral administration to male Wistar rats. JAN1, P. U., NOMURA, T., YAMASHITA, F., TAKAKURA, T., FLORENCE, A. T., and HASHIDA, M., J. Drug Target, 1996, 4 (2), 87–93.
  • Biodegradable cisplatin microspheres for direct brain injection: preparation and characterization. GARCIA, C. L., ABU, I. K., and Lu, D. R., Pharm. Dev. Technol., 1997, 2 (1), 53–65.
  • Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes. SACHSE, A., LEIKE, J. U., SCHNEIDER, T., WAGNER, S. E., ROSSLING, G. L., KRAUSE, W., and BRANDL, M., Invest. Radiol., 1997, 32 (1), 44––50.
  • Biological factors involved in blood clearance of liposomes by liver. Liu, D., Adv. Drug Delivery Rev., 1997, 24 (2,3), 201–213.
  • Biologically erodable microspheres as potential oral drug delivery systems. MATHIOWITZ, E., JACOB, J. S., JONG, Y. S., CARINO, G. P., CHICKERING, D. E., CHATURVEDI, P., SANTOS, C. A., VIJAYARAGHAVAN, K., MONTGOMERY, S., BASSETT, M., and MORRELL, C., Nature, 1997, 386 (6623), 410–414.
  • Cancer therapy with liposomal formulations of anticancer drugs. MASSING, U., Int. J. Clin. Pharmacol. Ther., 1997, 35 (2), 87–90. 19 refs.
  • Cardiac and pulmonary replacement gene therapy from donor hearts: ex vivo liposome-medicated transfection. DALESANDRO, J., AKIMOTO, H., GORMAN, C. M., MCDONALD, T. 0., THOMAS, R., LiGuirr, H. D., and ALLEN, M. D., J. Thorac. Cardiovasc. Surg., 1996, 111 (2), 416–422.
  • Cationic liposomes as an oligonucleotide carrier: mechanism of action. ZELPIIATI, 0., SZOKA, F. C., JR.y. Liposome Res., 1997, 7 (1), 31–49.
  • Cationic liposome-mediated expression of HIV-regulated luciferase and diphtheria toxin A genes in HeLa cells infected with or expressing HIV. KONOPKA, K., HARRISON, G. S., FELGNER, P. L., and NEJAT, D., Biochim. Biophys. Acta, 1997, 1356 (2), 185–197.
  • Cationic liposome-mediated gene transfer. GAO, X., HUANG, L., Gene Ther., 1995, 2 (10), 710–722. 92 refs.
  • Cationic liposomes enhanced firefly bioluminescent assay of adenosine 51-triphosphate disodium salt. KAMIDATE, T., KINKOU, T., and WATANABE, H., Anal-Biochem, 1997, 244 (1), 62–66.
  • Charachteristics of DNA-tagged liposomes allowing their use in capillary-migration, sand-wich-hybridization assays. RULE, G. S., MONTAGNA, R. A., DURST, R. A., Anal-Biochem, 1997, 244 (2), 260–269.
  • Characterization of liposome-mediated gene delivery expression, stability and pharmacoki-netics of plasmid DNA. THIERRY, A. R., RABINOVICH, P., PENG, B., MAHAN, L. C., BRYANT, J. L., and GALLO, R. C., Gene Ther., 1997, 4 (3), 226–237.
  • Characterization of a mannosylphospholipid liposome system for drug targeting to alveolar macrophages. SHAO, J., and MA, J. K. H., Drug Delivery, 1997, 4 (1), 43–48.
  • Characterization of a commercial liposome spray. RADES, T., GERKE, A., SCHUTZE, W., and MULLER, C. C., Pharmazie, 1997, 52 (1), 44–50.
  • Characterizing whispering-gallery modes in microspheres using a near-field probe. KNIGHT, J. C., DUBREUIL, N., Lt.:FEVRE, S. V., RAIMOND, J. M., HAROCHE, S., NATO ASI Ser., Ser E, 1996, 324, 291–298.
  • Clinical observations with topical liposome-encapsulated interferon alpha for the treatment of genital papilloma virus infections. FOLDVARI, M., and MORELAND, A., J. Liposome Res., 1997, 7 (1), 115–126.
  • Comparative pharmacokinetics and antitumor efficacy of doxorubicin encapsulated in soybean-derived sterols and poly(ethylene glycol) liposomes in mice. ()I, X. R., MAITANI, Y., NAGAI, T., and WEI, S. L., Int. y. Pharm., 1997, 146 (1), 31–39.
  • Comparison of systemic absorption of aqueous and liposomal lidocaine following intra-articular injection in rabbits. Hou, S. M., and YU, H. Y., Formos. Med. Assoc., 1997, 96 (2), 141–143.
  • Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles. RAMOS, H., BRAJTBURG, J., MARQUEZ, V., and CmEN, B. E., Drugs Exp. Clin. Res., 1995, 21(6), 211–216.
  • Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1. SZEBENI, J., WASSEF, N. M., HARTMAN, K. R., RUDOLPH, A. S., and ALVING, C. R., Transfusion (Bethesda, Md), 1997, 37 (2), 150–159.
  • Condensation of plasmid DNA with polylysine improves liposome-mediated gene transfer into established and primary muscle cells. VITIELLO, L., CHONN, A., WASSERMAN, J. D., DUFF, C., and WORTON, R. G., Gene. Ther., 1996, 3 (5), 396–404.
  • Controlled release of thyrotropin releasing hormone from microspheres: evaluation of release profiles and pharmacokinetics after subcutaneous administration. HEYA, T., MIKURA, Y., NAGAI, Y., FUTO, T., TOMIDA, Y., SHIMIZU, H., and TOGUCHI, H.,.7. Pharm. SCi., 1996, 83 (6), 798–801.
  • Cytomedical therapy for IgG1 plasmacytosis in human interleukin-6 transgenic mice using hybridoma cells microencapsulated in alginate-poly(L)lysine-alginate membrane. OKADA, N., MIYAMOTO, H., YOSHIOKA, T., KATSUME, A., SAITO, H., YOROZU, K., UEDA, 0., hop, N., MIZUGUCHI, H., NAKAGAWA, S., OlISUGt, Y., MAYUMI, T., Biochim. Biophys. Acta, 1997, 1360 (1), 53–63.
  • Delayed local treatment of rabbit tibial fractures with biodegradable cefazolin microspheres. JACOB, E., CIERNY, G. 3RD., ZORN, K., McNEnA., J. F., and FALLON, M. T., Clin. Orthop., 1997, (336), 278-285. Delivery of liposome-sequestered hydrophobic proteins to lysosomes of normal and Batten disease cells. ANSARI, N. H., HE, Q., COOK, J. D., WEN, J., and SRIVASTAVA, S.Neurosci.Res., 1997, 47 (3), 341–347.
  • Determination of the physical state of drug in microcapsule and microsphere formulations. DASH, A. K.,.7. Microencapsul., 1997, 14(1), 101–112.
  • Development of a novel bioactive formulation of vasoactive intestinal peptide in sterically stabilized liposomes. SEJOURNE, F., RUBINSTEIN, I., SUZUKI, H., ALKAN, 0. H., Pharm. Res., 1997, 14 (3), 362–365.
  • Developmental study of functionalized microspheres by low-temperature plasma technology. HARAGUCHI, T., YAMADA, K., IDE, S., HATANAKA, C., MATSUSHIMA, S., KUMADA, K., IJICH1, K., HATATE, Y., KAJIYAMA, T., Kitakyushu Kogyo Koto Senmon Gakko Kenku Hokoku, 1997, 30, 73–79.
  • Diclofenac sodium microcapsules: in vitro testing considerations. PALOMO, M. E., BALLESTEROS, M. P., and FRUTOS, P., Drug Den. Ind. Pharm., 1997, 23 (3), 273–283.
  • Dimethyl sulfoxide extraction method for the liquid chromatographic analysis of micro- encapsulated Vitamin D3. PASTORE, R. J., DUNNETT, R. V., and WEBSTER, G. K.,Agric.Food Chem., 1997, 45 (5), 1784–1786.
  • Direct evidence for uptake of intact liposomes encapsulating silver sulfadiazine by cultured human keratinocytes based on combined transmission electron microscopy and x-ray microanalysis. SCHAI,I.ER, M., WURM, R., and KORTING, H. C., Antimicrob. Agents Chemother., 1997, 41(3), 717–719.
  • Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues. TAKAKUWA, K., FUJITA, K., KIKUCHI, A., SUGAYA, S., YAHATA, T., AIDA, H., KURAHAYASHI, T., HASEGAWA, I., and TANAKA, K., jpn. y. Cancer Res., 1997, 88 (2), 166–175.
  • Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: phar-macokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. NORTHFELT, D. W., MARTIN, F. J., WORKING, P., VOLBERDING, P. A., RUSSELL, J., NEWMAN, M., AMANTEA, M. A., and KAPLAN, L. D., y. Clin. Pharmacol., 1996, 36 (1), 56–63.
  • Dynamics of lipid antioxidation and vitamin E recycle in liposome membranes. FUKUZAWA, K., SAWAMI, K., and IKEHATA, W., Vitamin E Kenkyu no Shinpo, 1995, 5 75–81.
  • Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. NORRIS, D. A., and SINKO, P. J., J. Appl. Polym. Sci., 1997, 63 (11), 1481–1492.
  • Effect of aging on arteriolar dilation induced by prostaglandin E (1) incorporated in lipid microspheres. HIROSE, M., CHUN, T. Y., and MIYAZAKI, M., J. Cardiovasc. Pharmacol., 1996, 27 (5), 749–751.
  • Effect of cepharanthine-containing liposomes on the phagocytotic activity of peritoneal macrophages. SHINODA, K., SATO, H., ADACHI, I., and HORIKOSHI, I., Drug Delivery Syst., 1997, 12(1), 57–61.
  • Effect of liposome encapsulated hemoglobin 'neo red cells' as a treatment agent for severe hemorrhagic shock and isovolemic hemodilution in dogs. Effects in hemodynamic variables, blood volume, and oxygen consumption. FUKUI, A., and TAKAORI, M., jinko Ketsueki, 1996, 4 (4), 98–104.
  • Effect of primary emulsions on microsphere size and protein-loading in the double emulsion process. MAA, Y. F., and Hsu, C. C., J. Microencapsul., 1997, 14 (2), 225–241.
  • Effect of processing parameters on the properties of peptide-containing PLGA microspheres. JEYANTHI, R., MEHTA, R. C., THANOO, B. C., and DELucA, P. P., J. microencosul., 1997, 14 (2), 163–174.
  • Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. DE VOS, P., DE HAAN, B., and VAN SCHILFGAARDE, R., Biomaterials, 1997, 18 (3), 273–278.
  • Effect of amphipathic PEG-PE on the circulation time of liposomes in vitro. ZHANG, J., and Hou, X., J. Clin. Pharm. Sci., 1996, 5 (2), 111.
  • Effect of drug properties on physical and release characteristics of Eudragit microspheres prepared by spherical crystallization technique. AKBUGA, J., and BERGISADI, N., Drug Dev. Ind. Pharm., 1997, 23(4), 407–411.
  • Effect of lung surfactant liposomes on the rabbit fetal lung type II cell antioxidant enzymes following prenatal dexamethasone treatment. GUPTA, A., MAJUMDAR, S., and SANYAI., S. N., Res. Exp. Med. (Berl), 1996, 196 (1), 67–76.
  • Effect of Steareth-20 on the release of nitrofurantoin from propylene glycol monostearate microspheres. TREK, S., SHOJAEI, A. H., and VASAVADA, R. C., Drug Dev. Ind. Pharm., 1997, 23 (3), 247–252.
  • Effects of oligodeoxynucleotides on the physicochemical characteristics and cellular uptake of liposomes. ARIMA, H., ARAMAKI, Y., and TSUCHIYA, 5,7. Pharm. Sci., 1997, 86 (4), 438–442.
  • Effects of alpha-tocopherol on 2,2'-azobis(2-amidinopropane) dihydrochloride-induced damage of liposome membrane. TAKEHARA, Y., KOBUCHI, K., KANNO, T., AKIYAMA, J., UTSUMI, K., KOBUCHI, K., YASUDA, T., and YOSHIOKA, T., Vitamin E Kenkyu no Shinpo, 1995, 5, 87–92.
  • Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo. BONCUK, P., KASER, M., Yu, Y., and TAEUSCH, H. W., Lipids, 1997, 32 (3), 247–253.
  • Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat peritoneal exudate cell populations. STORM, G., STEERENBERG, P. A., VAN BORSSUM, W. M., and CROMMELIN, D. J., J. Drug Target., 1996, 4 (4), 255–264.
  • Effects of lanthanides on membrane oxidation of liposome and red cells. WANG, X. F., Liu, X. T., and YANG, X. D., Shengrou Huaxue Zazhi, 1997, 13 (1), 108–112.
  • Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. NORTHEELT, D. W., DEZUBE, B. J., THOMMES, J. A., LEVINE, R., VON ROENN, J. H., DOSIK, G. M., Rios, A., KROWN, S. E., DUMOND, C., and MAMELOK, R. D., 7. Clin. Oncol., 1997, 15 (2), 653–659.
  • Efficient gene transfer method into the whole heart through the coronary artery with hemagglutinating virus of Japan liposome (see comments). SAWA, Y., KADOBA, K., SUZUKI, K., BA, H. Z., KANEDA, Y., SHIRAKURA, R., and MATSUDA, H., 7. Thorac. Cardiovasc. Surg., 1997, 113 (3), 512–518; discussion 518–519.
  • Encapsulation study of 6-methylprednisolone in lipid microspheres. SALMERON, M. D., HERNANDEZ, P. J., and CEREZO, A., Drug Dev. Ind. Pharm., 1997, 23 (2), 133–136.
  • Enhanced induction of tumor necrosis factor-.alpha. by OK-432/liposome complex in rodent macrophages. TAKASU, K., NAKATA, K., SEGAWA, T., MATSUKAWA. S., IZAWA, K., TSUNODA, T., OHATA, N., ISHII, N., Km', T., and KANEMATSU, T., Int. y. Immunother., 1996, 12(1/2), 11–17.
  • Entrapment of antibiotics in liposomes containing phosphatidylethanol. DAVYDOV, V. Y., KuLiE, L. N., and KISEL, M. A., Antibiot Khimioter, 1996, 41(5), 25–29.
  • Entrapment of plasmid DNA in liposomes. SONG, M., LEE, M. H., YONG, C. S., and Oft, D. M., Yakche Hakhoechi, 1996, 26 (4), 291–297.
  • Eudragit microcapsules of nifedipine and its dispersions in HPMC-MCC: physicochemical characterization and drug release studies. CHOWDARY, K. P. R., GIRIJA, G., Drug Dev. Ind. Pharm., 1997, 23 (3), 325–330.
  • Evaluation of dipalmitoylphosphatidylcholine liposomes containing a soybean-derived sterylglucoside mixture for liver targeting. SHIMIZU, K., MAITANI, Y. TAKAYAMA, K., and NAGAI, T.,.7. Drug Target., 1996, 4 (4), 245–253.
  • Evaluation of hypersensitivity to microencapsulated ampicillin in guinea pigs. BARSOUM, I. S., Kopyra.owsKi, K. M., CUENIN, P., and SETTERSTROM, J. A.,.7. Antimicrob. Chemother., 1997, 39 (1), 63–69.
  • Evaluation of cationic liposomes for delivery of diphtheria toxin A-chain gene to cells infected with bovine leukemia virus. LEE, J. T., WATARAI, S., KAKIDANI, H., ONUMA, M., ZHAO, D. D., and YASUDA, T.,Vet. Med. Sci., 1997, 59 (3), 169–174.
  • Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. PORTEOUS, D. J., DORIN, J. R., MCLACHLAN, G., DAVIDSON SMITH, H., DAVID, H., STEVENSON, B. J., CAROTHERS, A. D., WAI.I.ACE, W. A. H., MORAI.EE, S., HOENES, C., KALLMEYER, G., MICHAELIS, U., NAUJOKS, K., Ho, L. P., SAMWAYS, J. M., ImmE, M., GREENING, A. P., and INNES, J. A., Gene Ther., 1997, 4(3), 210–218.
  • Evidence for phospholipid microdomain formation in liquid crystalline liposomes reconsti-tuted with Escherichia coli lactose permease. LEHTONEN, J. Y., and KINNUNEN, P. K., Biophys. y., 1997, 72 (3), 1247–1257.
  • Fluorescence studies on the interaction of a synthetic signal peptide and its analog with liposomes. WANG, E, Ctn, D., and LIN, Q., Biochim. Biophys. Acta., 1997, 1324 (1), 69–75.
  • Folding of long DNA chains in the presence of distearyldimethylammonium bromide and unfolding induced by neutral liposomes. MEI. N., S. M., SERGEYEV, V. G., MEI., N. Y. S., and YOSHIKAWA, K., y. Chem. Sac, Faraday Trans., 1997, 93 (2), 283–288.
  • Forensic analysis of 10 barbiturates in human biological samples using a new reversed-phase chromatographic column packed with 2-micrometre porous microspherical silica-gel. TANAKA, E., TERADA, M., TANNO, K., MISAWA, S., and WAKASUGI, C., Forensic Sei. 1711., 1997, 85 (1), 73–82.
  • Formation of positively charged microcapsules based on chitosan-lecithin interactions. MAGDASSI, S., BACH, U., and Mumcoom.u, K. Y., y. Microencapsul., 1997, 14 (2), 189–195.
  • Formation of lipofuscin-like fluorophores by reaction of retinal and photoreceptor outer segments and liposomes. KATZ, M. L., GAO, C. L., and RICE, L. M., Mech. Ageing Dev., 1996, 92 (2,3), 159–174.
  • Formation of a macroscopic membrane structure by liposomes containing cationic lipids and exposed to DC electric fields. SODERLUND, T., LEHTONEN, J. Y. A., SIEVI, J. J., and KINNUNEN, P, K. J., Chem. Phys. Lipids, 1997, 85 (2), 107–114.
  • Frost resistance of antiwashout underwater concrete containing expanded plastic microspheres. AYUTA, K., SAKAI, K., and YAMAKAWA, T., Semento, Konkurito Ronbunshu, 1996, 50, 440–445.
  • Functional characterization of pediocin PA-1 binding to liposomes in the absence of a protein receptor and its relationship to a predicted tertiary structure. CHEN, Y., SHAPIRA, R., EISENSTEIN, M., and MONTVII.LE, T. J., Appl. Environ. Microbiol., 1997, 63 (2), 524–531.
  • Fusogenic liposome. MIZUGUCHI, H., NAKAGAWA, S., and MAYUMI, T., Igaku no Ayumi, 1997, 180 (11), 718–719.
  • Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. VELOSO, A. A. JR., Znu, Q., HERRERO, V. R., and REFOJO, M. F., Invest. Ophthalmol. Vis. Sci., 1997, 38 (3), 665–675. Gene therapy by means of liposomes. YAGI, K., Biotechnologia, 1996, (4), 17–25.
  • Hepatic accumulation of glutamic acid branched neogalactosyllipid modified liposomes. MURAHASHI, N., ISHIHARA, H., SASAKI, A., SAKAGAMI, M., and HAMANA, H., Biol. Pharm. Bull., 1997, 20 (3), 259–266.
  • Heterogeneous distribution of technetium-99m-labeled microspheres in rat lungs: micro-autoradiographic evidence and dosimetric consequences. ROBINSON, M. S., COLAS, L. C., GulaAun, V. F. M., PETIET, A. M., and BOK, B. D.J. Nucl. Med., 1997, 38 (4), 650–654.
  • High density culture of osteoblastic cells on collagen microspheres. Effects of direct current electrical stimulation. SUGIMURA, I., Nagoya-shiritsu Daigaku Igakkai Zasshi, 1997, 48 (1), 1–14.
  • Human epidermal melanocyte and keratinocyte melanocortin receptors: visualization by melanotropic peptide conjugated microspheres (latex beads). JIANG, J., SHARMA, S. D., HRUBY, V. I., BENTLY, D. L., FINK, J. L., and HADI.EY, M. E., Pigment Cell. Res., 1996, 9 (5), 240–247.
  • Imaging distribution of polymer microspheres in dispersion. ITo, K., Kobunshi, 1997, 46 (4), 255–257.
  • Immobilization of liposomes and proteoliposomes in gel beads. BREKKAN, E., YANG, Q., VIEL, G., LUNDAHL., P., Methods Biotechnol., 1 ( Immobilization of Enzymes and Cells), 1997, 193–206.
  • Impaired glucose tolerance in recipients of an intraperitoneally implanted microencapsu-lated islet allograft is caused by the slow diffusion of insulin through the peritoneal membrane. DE VOS, P., VEGTER, D., STRUBBE, J. H., DE HAAN, B. J., and VAN SCHILFGAARE, R., Transplant Proc., 1997, 29 (1/2), 756–757.
  • Importance of sebaceous glands in cutaneous penetration of an antiandrogen: target effect of liposomes. BERNARD, E., DuBois, J. L., and WEPIERRE, J.,7. Pharm. Sci., 1997, 86 (5), 573–578.
  • In vitro Biodegradation of polyhydroxybutyrate-hydroxyvalerate microcapsules exposed to Hank's buffer, newborn calf serum, pancreatin and synthetic gastric juice. ATKINS, T. W., and PEACOCK, S. J., J. Microencapsul., 1997, 14 (1), 35–49.
  • In vitro Ciprofloxacin release from poly(lactide-co-glycolide) microspheres. MARTINEZ, B., LAIEloN, F., PENA, M. B., DI Rocco, P., and NACUCCHIO, M. C., J. Microencapsul., 1997, 14 (2), 155–161.
  • In vitro dissolution of sulfadiazine microcapsules and its influencing factors. MAO, L., and ZHANG, R., Zhongguo Yiyao Gongye Zazhi, 1996, 27 (10), 442–447.
  • In vivo Evaluation of zidovudine (AZT)-loaded ethyl cellulose microspheres after oral administration in beagle dogs. ABU, I. K., TAMBRALLO, L., and Lu, D. R., y. Pharm. Sci., 1997, 86 (5), 554–559.
  • In vitro analysis of the release of incorporated agents from sodium caseinate microspheres. HEELAN, B. A., and CORRIGAN, 0. I., J. Microencapsul., 1997, 14 (1), 63–78.
  • In vitro controlled release kinetics of local anaesthetics from poly (D, L-lactide) and poly (lactide-co-glycolide) microspheres. LE CORRE, P., RYTTING, J. H., GAJAN, V., CHEVANNE, F., and LE VERGE, R., J. Microencapsul., 1997, 14 (2), 243–255.
  • In vivo distribution of radioactivity in mice after injection of biodegradable polymer micro-spheres containing 14C-labeled tetanus toxoid. GUPTA, R. K., CHANG, A. C., GRIFFIN, P., RIVERA, R., and SIBER, G. R., Vaccine, 1996, 14 (15), 1412–1416.
  • In vivo transfer efficiency of antisense ologonucleotides into the myocardium using HJV-liposome method. AOKI, M., MORISHITA, R., HIGAKI, J., MORIGUCHI, A., KIDA, I., HAYASHI, S., MATSUSHITA, H., KANEDA, Y., and OGIHARA, T., Biochem. Biophys. Res. Commun., 1997, 231 (3), 540–545.
  • Induction and maintenance of monocyte cytotoxicity during treatment with liposomes containing muramyl tripeptide despite tachyphylaxis to the cytokine response. GAI.I.IGIONI, E., FAVARO, D., SANTAROSA, M., QUAITA, M., SPADA, A., FRESCHI, A., and ALBERTI, D., Clin. Cancer Res., 1995, 1(5), 493–499.
  • Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. MEN, Y., GANDER, B., MERKLE, H. P., and CORRADIN, G., Vaccine, 1996, 14 (15), 1442–1450.
  • Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone. Lim, H. J., MASIN, D., MADDEN, T. D., and BALLY, M. B., J. Pharmacol. Exp. Ther., 1997, 281 (1), 566–573.
  • Influence of squeeze force on the release of tablet microencapsulated bisacodyl. SANCHEZ, I. P., COLARTE, A. I., DIAZ, I. A., MARTINEZ, G. J., and HERNANDEZ, E. U., Rev. Cubana Farm., 1995, 29 (2), 77–81.
  • Infrared quantitative study of acetylation of microspheres of polystyrene. Liu, X. N., BAYER, E., and XuE, G., Spectrosc. Lett., 1997, 30 (2), 289–295.
  • Inhibition of xanthine oxidase-xanthine-iron-mediated lipid peroxidation by eugenol in liposomes. NAGABABU, E., and LAKSIIMAIAH, N., Mol. Cell Biochem., 1997, 166 (1 & 2), 65–71.
  • Inhibition of lipoxygenase-mediated lipid peroxidation by eugenol in a liposomal system. NAGABABU, E., and LAKSHMAIAH, N., y. Clin. Biochem. Nutr., 1996, 21(2), 123–129.
  • Interactions between liposomes and chitosan II: effect of selected parameters on aggregation and leakage. HENRIKSEN, I., VAAGEN, S. R., SANDE, S. A., SMISTAD, G., and KARLSEN, J., rot. J. Pharm., 1997, 146 (2), 193–203.
  • Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. KHANNA, C., ANDERSON, P. M., HASZ, D. E., KATSANIS, E., NEVILLE, M., and KLAUSNER, J. S., Cancer, 1997, 79 (7), 1409–1421.
  • Intracellular drug delivery using pH- and light-activated diplasmenylcholine liposomes. GERASIMOV, 0., QUALLS, M., RUI, Y., and THOMPSON, D. H., Polym. Mater. Sci. Eng., 1997, 76, 499–500.
  • Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. SHINKAI, M., YANASE, M., HONDA, H., WAKABAYASHI, T., YOSHIDA, J., and KOBAYASHI, T., jpn. y. Cancer Res., 1996, 87(11), 1179–1183.
  • Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study. LAPPALAINEN, K., MIETTINEN, R., KELLOKOSKI, J., JAASKELAINEN, I., and SYRJANEN S., J. Histochem. Cytochem., 1997, 45 (2), 265–274.
  • Kinetics stability of liposomes. GROHMANN, F. L., CSEMPESZ, F., and SZOGYI, M., Acta Pharm. Hung., 1996, 66 (5), 197–202.
  • Labeling of RNA transcripts of eukaryotic cells in culture with BrUTP using a liposome transfection reagent (DOTAP). HAUKENES, G., SZILVAY, A. M., BROKSTAD, K. A., KANESTROM, A., and KALLAND, K. H., Biotechniques, 1997, 22 (2), 308–312.
  • Light microscopical observations on luminally administered dyes, dextrans, nanospheres and microspheres in the pre-epithelial mucus gel layer of the rat distal colon. SZENTKUTI, L., J. Controlled Release, 1997, 46 (3), 233–242.
  • Limitations of cationic liposomes for antisense oligonucleotide delivery in vivo. LITSINGER, D. C., J. Liposome Res., 1997, 7(1), 51–61.
  • Lipid/DNA complexes as an intermediate in the preparation of particles for gene transfer: an alternative to cationic liposome/DNA aggregates. BALLY, M. B., ZHANG, Y. P., WoNG, F. M. P., KONG, S., WASAN, E., and REIMER, D. L., Adv. Drug Delivery Rev., 1997, 24(2,3), 275–290.
  • Liposomal induction of NO synthase expression in cultured vascular smooth muscle cells. SCOTT, B. T., ENGLER, D. A., TocK, C. L., SCHWARZ, J. J., and CASSCELLS, S. W., Biochem. Biophys. Res. Commun., 1997, 231 (3), 780–783.
  • Liposomal delivery of oligodeoxynucleotides. TAR], A., KHODADADIAN, M., ELLERSON, D., DEISSEROTH, A., and LOPEZ, B. G., Leuk. Lymphoma, 1996, 21(1-2), 93–97.
  • Liposomal delivery system for taxol. SIIIEII, M. F., CHU, I. M., LEE, C. J., KAN, P., HAU, D. M., and SHIEH, J. J., J. Ferment. Bioeng., 1997, 83 (1), 87–90.
  • Liposomal doxorubicin: Doxil. PATEL, J. J. Oncol. Pharm. Pract., 1996, 2 (4), 201–210.
  • Liposomal drug delivery. RANSON, M., HOWELL, A., CHEESEMAN, S., and MARGISON, J., Cancer Treat. Rev., 1996, 22 (5), 365–379. 137 Refs.
  • Liposomal formulation of netilmicin. Mums°, I. M., FRANCISCO, A. P., and CRUZ., M. E., Int. y. Pharm., 1997, 147(1), 109–117.
  • Liposomal transdermal preparations of low molecular weight heparin. ZHAI, G., Zou, L., ZHANG, T., Yaoult Shengum jishu, 1996, 3 (4), 221–223.
  • Liposome solubilization and membrane protein reconstitution using Chaps and Chapso. CI.ADERA, J., RIGAUD, J. L., VILLAVERDE, J., and DUNACH, M., Eur. J. Biochem., 1997, 243 (3), 798–804.
  • Liposome and polylysine mediated gene transfer. DESIIMUKH, H. M., and HUANG, L., New y. Chem., 1997, 21 (1), 113–124.
  • Liposome turbidimetric assay (LTA). UENo, T., TANAKA, S., and UMEDA, M., Adv. Drug Delivery Rev., 1997, 24 (2,3), 293–299.
  • Liposome-encapsulated superparamagnetic iron oxide particles as markers in an MRI-guided search for tumor-specific drug carriers. PAUSER, S., RESZKA, R., WAGNER, S., WOLF, K. J., BUHR, H. J., and BERGER, G., Anticancer Drug Des., 1997, 12 (2), 125–135.
  • Liposome-encapsulated ampicillin: physicochemical and antibacterial properties. SCHU-MACHER, I., and X RimoNA, M., J. Pharm. Sc., 1997, 86 (5), 635–641.
  • Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice. RuooLPH, A. S., CLIFF, R., KWASIBORSKI, V., NEVILLE, L., Alloul.i,Ati, F., RABINOVICI, R., Crit. Care Med., 1997, 25 (3), 460–468.
  • Liposome-mediated monocyte depletion during wallerian degeneration defines the role of hematogenous phagocytes in myelin removal. BRUCK, W., HUITINGA, I., DIJKSTRA, C. D., J. Neurosci. Res., 1996, 46 (4), 477–484.
  • Liposomes for drug targeting in the lymphatic system. HIRNLE, P., Hybridoma, 1997, 16(1), 127–132.
  • Liposomes from phosphatidyl nucleosides: an NMR investigation. BONACCIO, S., CAPITANI, D., SEGRE, A. L., WALDE, P., Luis, P. L., Langmuir, 1997, 13 (7), 1952–1956.
  • Liposomes in cancer chemotherapy. DEMETZOS, K., Chem. Chron, Genike Ekdose, 1996, 58 (12), 657–660.
  • Liposomes in dermatotherapy. CORTADA, D. G., and Diouit, N. A., Rev. Cubana Farm., 1996, 30 (2), 132–139.
  • Liposomes: general charactersitics and their role in the chemical stability of sensitive drugs. LOUKAS, G. L., Chem Chron, Genike Ekdose, 1996, 58 (12), 654–656.
  • Liposomes: vehicles for the targeted and controlled delivery of peptides and proteins. CROMMELIN, D. J. A., DAEMEN, T., SCHERPHOF, G. L., VINGERHOEDS, M. H., HEEREMANS, J. L. M., KLUFT, C., and STORM, G., y Controlled Release, 1997, 46 (1,2), 165–175.
  • Liposomes: delivery systems for novel therapeutic agents. PAYLOR, P. W., Polym. Mater. Sci. Eng., 1997, 76, 495–496.
  • Local and systemic immune response to a microencapsulated sub-unit vaccine for plague. WILLIAMSON, E. D., SHARP, G. J., ELEY, S. M., VESEY, P. M., PEPPER, T. C., TITBALL, R. W., and ALPAR, H. 0., Vaccine, 1996, 14 (17-18), 1613–1619.
  • Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals. GARizoN, A., GOREN, D., HOROWITZ, A. T., TZEMACH, D., Lossos, A., SIEGAL, T., Adv. Drug Delivery Rev., 24 (2,3), 337–344.
  • Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antituber-cular drugs in mice. DEOL, P., and KHULLER, G. K., Biochim. Biophys. Acta., 1997, 1334 (2-3), 161–172.
  • Macroaggregated albumin potentiates the hypoglycemic effect of microencapsulated islets in the fed state of streptozotocin-induced diabetic mice. Hsu, A. W., Fu, S. H., HUANG, Y. Y., Hsu, A. W., CHUANG, K. L., and HUANG, H. S., J. Microencapsul, 1997, 14 (1), 27–34.
  • Measurement of blood flow with radiolabeled microspheres in reflected mucogingival flaps in cats. WUCHENICH, G. T., TORABINEJAD, M., GILBERT, R. D., and MCMILLAN, P., Oral. Surg. Oral. Pathol. Oral. Radial. Endod., 1996, 82 (3), 330–334.
  • Microencapsulated pigment and its application to liquid toner. Control of negative charge. YABUUCHI, N., MAGOSHI, A., SHIBAI, Y., and Istm, K., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1997, 38 (1), 408–409.
  • Microencapsulated Eudragit RS30D-coated controlled-release pellets: the influence of dis-solution variables and topographical evaluation. GOVENDER, T., DANGOR, C. M., and CHEWY, D. J., J. Microencapsul., 1997, 14 (1), 1–13.
  • Microencapsulated aluminium powders. NEIKOV, 0. D., RABIN, P. B., and VASILIYEVA, G. I., Mater. Sci. Forum, 1997, 242 (Aluminium Alloys, Pt. 4/Suppl.), 219–222.
  • Microencapsulation of nifedipine-MCC solvent deposited system for sustained release. CHOWDARY, K. P. R., NAGARAJAN, M., and NALLURI, B. N., Indian J. Pharm. Sci., 1996, 58 (4), 152–156.
  • Microencapsulation of theophylline using ethylcellulose: in vitro drug release and kinetic modelling. LAVASANIFAR, A., GHALANDARI, R., ATAEI, Z., ZOLFAGHARI, M. E., and MORTAZAVI, S. A., J. Microencapsul., 1997, 14 (I), 91–100.
  • Microencapsulation of thermal-sensitive pigment with inorganic wall material by interfacial reaction in multiple dispersion. KIMURA, I., IKARASHI, S. I., SAITO, N., and TANAKA, M., Adv. Powder Technol., 1997, 8 (1), 1–13.
  • Mitoxantrone-ethyl cellulose microspheres for liver arterial embolism. ZHANG, Z., WANG, D., LIAO, F., and LIAO, G., J. Chin. Pharm. Sci., 1996, 5 (4), 200–206.
  • Modulation of noninduced and phorbol ester-induced generation of superoxide anion by free liposomes and liposomes containing dexamethasone. BELLEMARE, F., and ROCHELEAU, H., Immunopharmacol. Immunotoxicol., 1997, 19 (1), 121–134.
  • Modulation of silica-induced pulmonary toxicity by dexamethasone-containing liposomes. DIMATTEO, M., and REASOR, M. J., Toxicol. Appl. Pharmacol., 1997, 142 (2), 411–421.
  • Modulation of pharmacokinetic behavior of liposomes. SCHERPHOF, G. L., VELINOVA, M., KAMPS, J., DONGA, J., VAN DER WANT, H., KUIPERS, F., HAEKES, L., DAEMEN, T., Adv. Drug Delivery Rev., 1997, 24 (2,3), 179–191.
  • Natural convection heat transfer enhancement using microencapsulated phase-change-material slurries. KUBO, S., AKINO, N., TANAKA, A., NAKANO, F., and NAGASHIMA, A., Therm. Sci. Eng., 1997, 5 (1), 9–13.
  • Negatively charged liposomes inhibit tyrosine phosphorylation of 41-k Da protein in murine macrophages stimulated with LPS. ARAMAKI, Y., MA'FSUNO, R., NITTA, F., ARIMA, H., and TSUCHIYA, S., Biochem. Biophys. Res. Commun., 1997, 231 (3), 827–830.
  • New porous microsphere of bisphenol A epoxy resin. YANG, Z., XU, Y., Yu, H., and ZHAO, D., Gaofenzi Xuebao, 1997, (1), 119–120.
  • Oligonucleotide therapeutics: lessons from sterically stabilized liposomes. WOODLE, M. C., HUANG, S. K., MEYER, Q., BROWN, B. D., DIZIK, M., HONG, K., and PAPAHADJOPOULOS, D., Adv. Drug Delivery Rev., 1997, 24 (2,3), 273.
  • Optimization of technetium-99m-labeled PEG liposomes to image focal infection: effects of particle size and circulation time. BOERMAN, 0. C., OYEN, W. J., VAN BLOOIS, L., KOENDERS, E. B., VAN DER MEER, J. W., CORSTENS, F. H., and STORM, G., J. Nod. Med., 1997, 38 (3), 489–493.
  • Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates. PERIWAL, S. B., SPEAKER, T. J., and CERRA, J. J., J. Virol., 1997, 71(4), 2844–2850.
  • pH-dependent cellulosic microspheres containing cefuroxime azetil: stability and in vitro release behavior. CUNA, M., LORENZO, L. M. L., VILA, J. J. L., TORRES, D., and AI.ONSO, M. J., Drug Dev. Ind. Pharm., 1997, 23 (3), 259–265.
  • pH-sensitive liposomes: an intelligent system for the delivery of antisense oligonucleotides. COUVREUR, P., FATTAL, E., MALVY, C., and DUBERNET, C., Y. Liposome Res., 1997, 7 (1), 1–18.
  • Pharmacokinetic study of taxol-loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. SATO, H., WANG, Y. M., ADACHI, I., and HORIKOSFII, I., Biol. Pharm. Bull., 1996, 19 (12), 1596–1601.
  • Pharmacokinetics of liposomal amphotericin B during hemodiafiltration. TOMLIN, M., BASARAB, A., and WARNOCK, D. W Clin. Drug Invest., 1997, 13 (2), 118–120.
  • Phase behavior of flurocarbon di-0-alkyl-glycerophosphocholines and glycerphosphoeth-anolamines and long-term shelf stability of fluorinated liposomes. RAVILY, V., SAN TAELLA, C., VIERLING, P., and GUI.IK, A., Biochim. Biophys. Acta., 1997, 1324 (1), 1–17.
  • Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. PEREZ, S. R., SHIN, D. M., SIDDIK, Z. H., MURPHY, W. K., HUBER, M., LEE, J. S., KHOKHAR, A. R., and HONG, W. K., Clin. Cancer Res., 1997, 3 (3), 373–379.
  • Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. MUGGIA, F. M., HAINSWORTH, J. J., JEFFERS, S., MILLER, P., GROSHEN, S., TAN, M., ROMAN, L., UZIELY, B., MunEaspAc0, L., GARCIA, A., BURNETT, A., GRECO, F. A., MORROW, C. P., PARADISO, L. J., and LIANG, L. J., J. Clin. 1997, 15 (3), 987–993.
  • Photodynamic therapy of 9L gliosarcoma with liposome-delivered Photofrin. JIANG, F., LII,GE, L., LOGIE, B., LI, Y., and CHOPP, M., Photochem. Photobiol., 1997, 65 (4), 701–706.
  • Physical properties and tissue distribution of adriamycin encapsulated in polyethylene glycol-coated liposomes. SADZUKA, Y., HIROTA, S., Adv. Drug Delivery Rev., 1997, 24 (2,3), 257–263.
  • Physicochemical features of L-3,4-dihydroxyphenylalanine (DOPA) and dopamine encapsu-lated in liposomes. BoalsovA, N. V., KAPLUN, A. P., BOGOMOLOV, 0. V., GRIGOR, E. V. B., YURASOV, V. V., NIKUSIIKIN, E. V., KRYZHANOVSKII, G. N., and SIIVETS, V. I., Bioorg. Khim., 1996,22 (10-11), 846–851.
  • Pillared rectorite microspheric catalyst for cracking heavy oil. GUAN, J., Yu, Z., CHEN, Z., LIU, Q., WANG, X., Prepr. Am. Chem. Soc., Div. Pet. Chem., 1997, 42 (2), 489–492.
  • Plasma factors affecting disposition of liposomes. KiwAtm, H., Adv. Drug Delivery Rev., 1997, 24 (2,3), 193–199.
  • Poly(ethylene oxide)-bearing lipids reconstituted in liposomes and their biological functions. SUNAMOTO, J., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1997, 38 (1), 537–538.
  • Poly(ethylene oxide) coated liposomes: theory and practice. LASIC, D. D., Polym. Prepr. (Am. Chem. Soc., Div. Polym. ('hem.), 1997, 38 (1), 543–544.
  • Polyethylene glycol-liposomal doxorubicin: a review of its pharmacodynamic and pharma-cokinetic properties, and therapeutic efficacy in the management of AIDS-related Kaposi's sarcoma. COUKELL, A. J., and SPENCER, C. M., Drugs, 1997, 53 (3), 520–538.
  • Polyethylene glycols effectively increase the liposomal-encapsulated SOD concentration in blood circulation. HIRATA, I., KANFIAYASHI, Y., KtSFIIMOTO, H., YOSHIKAWA, T., NAITO, Y., KoNno, M., and NOSAKA, K., Fun i Rajikaru no Rinsho, 1995, 9, 91–93.
  • Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. AMANTEA, M. A., FORREST, A., NORTHFELT, D. W., and MAMELOK, R., Clin. Pharmacol. Then., 1997, 61(3), 301–311.
  • Preclinical trial of doxorubicin entrapped in sterically stabilized liposomes in dogs with spontaneously arising malignant tumors. VAII., D. M., KRAVIS, L. D., COOLEY, A. J., CHUN, R., and MACEWEN, E. G., Cancer Chemother. Pharmacol., 1997, 39 (5), 410–416.
  • Preparation and characterization of oligosaccharide- and oligopeptide-bearing Stealth liposomes. GITTEI.MAN, J., HARDING, J., MULLAH, N., Gun, L., DE FREES, S., and ZALIPSKY, S., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1997, 38 (1), 607.
  • Preparation and evaluation of chondroitin sulfate/gelatin microspheres containing dexa-methasone 21-acetate. YONG, C. S., KIM, Y. J., and On, D. M., Yakche Hakhoechi, 1996, 26 (4), 273–280.
  • Preparation and release properties of biodegradable chitin microcapsules: I. Preparation of 6-mercaptopurine microcapsules by phase separation methods. MI, F. L., TSENG, Y. C., CHEN, C. T., and SHYU, S. S., J. miernencapsni., 1997, 14 (1), 15–25.
  • Preparation and release properties of biodegradable chitin microcapsules: II. Sustained release of 6-mercaptopurine from chitin microcapsules. MI, F. L., TSENG, Y. C., CHEN, C. T., and SHYU, S. s., y. Microencapsul., 1997, 14(2), 211–223.
  • Preparation and characterization of polylactic acid microspheres containing water-soluble anesthetics with small molecular weight. UCHIDA, T., YosHinA, K., NAKADA, Y., NAGAREYA, N., KONISHI, Y., NAKAI, A., NISHIKATA, M., and MATSUYAMA, K., Chem. Pharm. Bull., 1997, 45 (3), 513–517.
  • Preparation and stabilization of heparin/gelatin complex coacervate microcapsules. TBUNG, M., and BURGESS, D. J., J. Pharm. Sci., 1997, 86 (5), 603–607.
  • Preparation of cefaclor-containing gelatin microcapsules and their drug release characteristics. CHO, W., PARK, J. H., PARK, J. S., JANG, J. S., and CHOI, Y. W., Yakhak Hoechi, 1997, 41(1), 30–37.
  • Preparation of slow release microcapsules containing nutrient by fluidized bed coating method. YOKOTA, Y., PONDEVIDA, J. L., and ALFONSO, C. F., Philipp. J. sci., 1996, 125 (2), 95–108.
  • Preparation of biodegradable microcapsules with (W/O/W) emulsion and solvent evaporation. KIYOYAMA, S., SHIOMORI, K., BABA, Y., KAWANO, Y., YOSHIZAWA, H., and HATATE, Y., Kagaku Kogaku Ronbunshu, 1997, 23 (2), 259–265.
  • Preparation of crosslinked microcapsules with spherical pores by in situ polymerization in (W/O/W) emulsion system. I.octc, K., and HATATE, Y., Kagaku Kogaku Ronbunshu, 1997, 23 (2), 303–306.
  • Preparation of giant liposomes in physiological conditions and their characterization under an optical microscope. AKASHI, K., MIYATA, H., hos, H., KINOSITA, K. JR., Biophys. y., 1996, 71(6), 3242–3250.
  • Preparation and antitumor effect of taxol-containing liposome. YAN, J., TONG, Y., and WANG, J., Vomit Shengum jishu, 1996, 3(3), 154–157.
  • Preparation of microcapsule toner and their properties. TANAKA, M., IMURA, I., SAITO, N., and TOMINAGA, H., Kona, 1996, 14, 153–161.
  • Preparation of oral polymeric microspheres carrying vaccine. LI, X., Juk, W., XIAO, J., DENG, X., MENG, L., and ZHENG, Z., Zhongguo Yaoxue Zazhi (Beijing), 1996, 33 (11), 661-664. Preparation of polyphosphazene hydrogel microspheres by coacervation. ANDRIANOV, A. K., CHEN, J., and PAYNE, L. G., Polym. Mater. Sci. Eng., 1997, 76, 365–366.
  • Preparation of sulfadiazine microcapsules. MENG, S., and ZHAO, G., Zhongguo Yiyuan Yaoxue Zazhi, 1996, 16 (10), 451–452.
  • Prolonged retention of cross-linked trypsin in calcium alginate microspheres. CHUI, W. K., and WAN, L. S., J. Microencapsul., 1997, 14 (1), 51–61.
  • Protective effect of plant flavonoids on the oxidation of lecithin liposomes. GABRIELSKA, J., OSZMIANSKI, J., and LAMER, Z. E., Pharmazie, 1997, 52 (2), 170–171.
  • Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro. DUNCAN, J. E., Wonsorr, J. A., and HOROWITZ, A. D., Hum. Gene Ther., 1997, 8 (4), 431–438.
  • Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Tolerance and safety. WALDREP, J. C., GILBERT, B. E., KNIGHT, C. M., BLACK, M. B., SCIIERER, P. W., KNIGHT, V., and ESCHENBACHER, W., Chest, 1997, 111 (2), 316–323.
  • Purified leukocyte cytochrome b558 incorporated into liposomes catalyzes a cytosolic factor dependent diaphorase activity. Li, J. R., and GUILLORY, R. J., Biochemistry, 1997, 36 (18), 5529–5537.
  • Rapid reconstitution of tonoplast H+-translocating pyrophosphatase from cultured rice cells into liposomes. NAKAMURA, Y., SAKAKIBARA, Y., KOBAYASHI, H., and KASAMO, K., Plant Cell Physiol., 1997, 38 (3), 371–374.
  • Reaction of lipid peroxy-radicals and .alpha.-tocopherol in phospholipid liposome membranes. YAMAUCHI, R., YAGI, Y., and KATO, K., Vitamin E Kenkyu no Shinpo, 1995, 5, 69–74.
  • Recent developments in ligand-bearing polymer-grafted liposomes. ZALIPSKY, S., Polym. Prepr. (Am. Chem. Soc., Div, Polym. Chem.), 1997, 38 (1), 539–540.
  • Receptor-mediated transfer pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. HARA, T., ARANIAKI, Y TAKADA, S., KOIKE, K., and TSUCIIIYA, S., Gene. Ther., 1995, 2 (10), 784–788.
  • Release rates from semi-crystalline polymer microcapsules formed by interfacial polycondensation. YADAV, S. K., KHILAR, K. C., and SURESH, A. K., J. Membr. Sci., 125 (2), 213–218.
  • Role of saccharides for the freeze-thawing and freeze-drying of liposome. MIYAJIMA, K., Adv. Drug Delivery Rev., 1997, 24 (2,3), 151–159.
  • Safety studies of the intraperitoneal injection of E1A-liposome complex in mice. XING, X., Liu, V., XIA, W., STEPHENS, L. C., HUANG, L., LOPEZ, B. G., and HUNG, M. C., Gene Ther., 1997, 4 (3), 238–243.
  • Scintigraphic visualization of intrathecal liposome biodistribution. UMBRAIN, V., D'HAESE, J., ALAFANDY, M., DE ROOVER, E., SCHOUTENS, A., VAN GANSBEKE, B., ALBERT, A., GOFFINET, G., CAMU, F., and LEGROS, F. J., Acta. Anaethesiol. Scand., 1997, 41(1 Pt 1), 25–34.
  • Screening and biological evaluation of liposomal formulations containing Adriamycin. YACHI, K., YAMAUCHI, H., and KIKUCHI, H., Adv. Drug Delivery Rev., 1997, 24 (2,3), 123–131.
  • Selective delivery of 5-fluorouracil (5-FU) to i.p. tissues using 5-FU microspheres in rats. HAGIWARA, A., SAKAKURA, C., TSUJIMOTO, H., IMANISHI, T., OHGAKI, M., YAMASAKI, J., SAWAI, K., TAKAHASIII, T., FUJITA, T., YAMAMOTO, A., MURANISIII, S., and IKADA, Y., Anti Cancer Drugs, 1997, 8 (2), 182–188.
  • Serum-liposome interaction is an oxygen-dependent process. FORADADA, M., MANZANO, A., Row, T., ESTELRICH, J., and BERMUDEZ, J., Biochim. Biophys. Acta., 1997, 1345 (1), 43–55.
  • Simultaneous determination of carbamazepine and its metabolites in plasma from carbon tetrachloride-intoxicated rats using a new reversed-phase chromatographic column of 2-microns porous microspherical silica gel. TANAKA, E., 1. ChromatogT. B. Biomed. Appl., 1997, 688 (1), 155–160.
  • Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. KERSTEN, G. F., DONDERS, D., AKKERMANS, A., and BEUVERY, E. C., Vaccine, 1996, 14 (17-18), 1627–1632.
  • Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres. TABATA, Y., INouE, Y., and IKADA, Y., Vaccine, 1996, 14 (17-18), 1677–1685.
  • Size-recognition in mechanism biological fate of liposomes. KiwADA, H., Pharm. Tech. jpn., 1997, 13 (2), 233–240.
  • Solubilizing effects caused by the nonionic surfactant dodecylmaltoside in phosphatidylcho-line liposomes. DE LA MAZA, A., and PARRA, J. L., Biophys. y., 1997, 72 (4), 1668–1675.
  • Specific inhibition of influenza virus RNA polymerase and nucleoprotein genes expression by liposomally endocapsulated antisense phosphorothioate oligonucleotides: penetration and localization of oligonucleofides. HATTA, T., TAKAI, K., NAKADA, S., YOKOTA, T., and TAKAKU, H., Biochem. Biophys. Res. Commun., 1997, 232 (2), 545–594.
  • Spectral properties of 3,3 Cdiethyloxadicarbocyanine included in phospholipid liposomes. SIDOROWICZ, A., Pol.A, A., and DOBRYSZYCKI, P., J. Photochem. Photobiol., 1997, 38 (1), 94–97.
  • Spermidine-condensed DNA and cone-shaped lipids improve delivery and expression of exogenous DNA transfer by liposomes. IBANEZ, M., GARIGLIO, P., CHAVEZ, P., SANTIAGO, R., WoNc, C., and BAEZA, I., Biochem. Cell Biol., 1996, 74 (5), 633–643.
  • Spontaneous formation of giant liposomes from neutral phospholipids. MAGOME, N., TAKEMURA, T., and YOSHIKAWA, K., Chem. Lett., 1997, (3), 205–206.
  • Stable polymeric liposomes from 1,2-Di-(9-(2E,4E)-hexadienyloxycarbonylnonanoy1)-sn-gly-cero-3-phosphocholine. RuNovA, T. L., ANIKIN, A. V., ANIKIN, M. V., and SEBYAKIN, Y. L., Bioorg. Khim., 1996, 22 (10-11), 809–813.
  • Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres. CLELAND, J. L., and JONES, A. J., Pharm. Res., 1996, 13 (10), 1464–1475.
  • Starch microspheres as carriers for x-ray imaging contrast agents: synthesis and stability of new amino-acid linker derivatives. RONGVED, P., KLAVENESS, J., and STRANDE, P., Carbo-hydr. Res., 1997, 297 (4), 325–331.
  • Steady-state proton translocation in bovine heart mitochondrial bc 1 complex reconstituted into liposomes. Cocco, T., Di PAoi.A, M., MINUTO, M., CARLIN°, V., PAPA, S., and LoRusso, M., J. Bioenerg. Biomembr., 1997, 29 (1), 81–87.
  • Stealth liposomes: from theory to product. CEH, B., WINTERHALTER, M., FREDERIK, P. M., VALLNER, J. J., and LASIC, D. D., Adv. Drug Delivery Rev., 1997, 24 (2,3), 165–177.
  • Strategies for increasing the circulation times of liposomes. ALLEN, T. M., and ZALIPSKY, S., Polyrn. Mater. Sci. Eng., 1997, 76, 497–498.
  • Structural stability and in vivo biological activity of ribonuclease A during microencapsula-tion into biodegradable polymers. NEI.I.ORE, R. V., and BHAGAT, H. R., Drug Delivery, 1997, 4 (1), 49–55.
  • Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar mem-branes in distinct interhelical packing regimes. RAEDER, J. 0., KOLTOVER, I., SALoirr, T., SANYA, C. R., Science (Washington, D C), 1997, 275 (5301), 810–814.
  • Studies of methemoglobin interactions with liposomes using the fluorescent probe DSM and its derivatives. GORBENKO, G. P., Ukr. Biokhim. Zh., 1996, 68 (3), 111–116.
  • Studies on oral sustained-release microspheres of nifedipine. Fu, C., JEANG, X, Hu, J., and Wu, W., Yaoxue Xuebao, 1996, 31(9), 706–711.
  • Study of choroidal blood flow by comparison of SLO fluorescein angiography and microspheres. DUIJIM, H. F., Rui.o, A. H., ASTIN, M., MAEPEA, 0., VAN DEN BERG, T. J., and GREVE, E. L., Exp. Eye Res., 1996, 63 (6), 693–704.
  • Supramolecular lipidic drug delivery systems from laboratory to clinic. A review of the recently introduced commercial liposomal and lipid-based formulations of amphoter-icin B. HILLERY, A. M., Adv. Drug Delivery Rev., 1997, 24 (2,3), 345–363.
  • Surface-modified liposomes in .gamma.-(ray scintigraphic) and MR- imaging. TORCHILIN, V. P., Adv. Drug Delivery Rev., 1997, 24 (2,3), 301–313.
  • Sustained elevated serum somatotropin concentrations in Holstein steers following subcu-taneous delivery of a growth hormone releasing factor analog dispersed in water, oil or microspheres. FOSTER, T. P., MOSELEY, W. M., CAPUTO, J. F., ALANIZ, G. R., LEATHERNIAN, IV. W., Yu, X., CI.AFLIN, W. H., REEVES, D. R., CLEARY, D. L., ZANTELLO, M. R., KRABILL, L. F., and WIEST, J. R., J. Controlled Release, 1997, 47 (1), 91–99.
  • Sustained release of a water-soluble GP Hb/Illa antagonist from copoly(DL-lacticiglycolic) acid microspheres. TAKADA, S., KUROKAWA, T., MIYAZAKI, K., IWASA, S., and OGAWA, Y., ha. J. Pharm., 1997, 146 (2), 147–157.
  • Synthesis of spherical microcapsules by photopolymerization in aerosols. ESEN, C., KAISER, T., BORCHERS, M. A., and SCI-IWEIGER, G., Colloid. Polym. Sci., 1997, 275 (2), 131–137.
  • Synthesis of poly(methacrylic acid) core/polystyrene shell type polymer microspheres. SAITO, R., TANAKA, S., and Istuzu, K., Polymer, 1997, 38 (7), 1725–1729.
  • Synthesis of monodisperse polymer microspheres. Liu, K., YANG, W., Youkuangye, 1996, 15 (3), 165–169.
  • Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. Kim, M. K., CHUNG, S. J., LEE, M. H., Coo, A. R., and Sum, C. K., J. Controlled Release, 1997, 46 (3), 243–252.
  • Taste receptor proteins directly extracted by liposome from intact epithelium of bullfrog tongue. NAKAMURA, M., TSUJI', K., and SUNAMOTO, J., Nippon Aji to Nioi Gakkaishi, 1996, 3 (3), 514–517.
  • Temperature-sensitivity of liposomal lipid bilayers mixed with poly (N-isopropylacrylamide-co-acrylic acid). KIM, J. C., BAE, S. K., and Kim, J. D., J. Biochem., (Tokyo), 1997, 121 (1), 15–19.
  • The effects of glucose oligomers (maltodextrins) on freeze-drying liposomes. OZAKI, K., and HAYASHI, M., Chem. Pharm. Bull., 1997, (Tokyo), 45 (1), 165–170.
  • The proton permeability of liposomes made from mitochondrial inner membrane phospho-lipids: comparison with isolated mitochondria. BROOKES, P. S., ROLFE, D. F. S., and BRAND, M. D., J. Membr. Biol., 1997, 155 (2), 167–174.
  • The influence of Pseudomonas aeruginosa on liposomes. ANTOS, M., TRAFNY, E. A., and GRZYBOWSKI, J., Folia. Microbiol. (Praha), 1996, 41(1), 29–32.
  • The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine librosarcoma tumors. MAYER, L. D., DOUGHERTY, G., HARASYM, T. 0., and BALLY, M. B., J. Pharmacol. Exp. Ther., 1997, 280 (3), 1406–1414.
  • The synthesis of chitosan microspheres for macromolecular drugs slow-release. XIN, J., ZHANG, F., and Li, D., Tianran Chanwu Yanjiu Yu Kaija, 1996, 8 (3), 92–95.
  • Therapeutic efficacy of liposomal clofazimine against Mycobacteriom avium complex in mice depends on size of initial inoculum and duration of infection. KANSAL, R. G., GOMEZ, F. R., SINHA, I., and MEHTA, R. T., Antimicrob. Agents Chemother., 1997, 41(1), 17–23.
  • Three-dimensional liposome networks: freeze fracture electron microscopical evaluation of their structure and in vitro analysis of release of hydrophilic markers. BAND, M., TARIM, C., DRESCHSLER, M., BACHMANN, D., RESZKA, R., BAUER, K. H., and SCHUBERT, R., Adv. Drug Delivery Rev., 1997, 24 (2,3), 161–164.
  • Topical liposomal system for localized and controlled drug delivery. SINGH, R., and VYAS, S. P., .7. Dermatol. Sci., 1996, 13 (2), 107–111.
  • Topographic organization of projection from the parabigeminal nucleus to the superior colliculus in the ferret revealed with fluorescent latex microspheres. JIANG, Z. D., KING, A. J., and MOORE, D. R., Brain Res., 1996, 743 (1-2), 217–232.
  • Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro. Xu, L., PIROLLO, K. F., and CHANG, E. H., Hum. Gene Ther., 1997, 8 (4), 467–475.
  • Transplantation of parathyroid tissue in experimental hypoparathyroidism: in vitro and in vivo function of parathyroid tissue microencapsulated with a novel amitogenic alginate. HASSE, C., KLOECK, G., ZIELKE, A., SCHLOSSER, A., BARTH, P., ZIMMERMANN, U., and ROTHMUND, M., Int. J. Artif. Organs, 1996, 19 (12), 735–741.
  • Treatment of breast cancer by local hyperthermia combined with thermo-sensitive liposo-mal adriamycin. YUAN, R., YAO, J., CHEN, C., and YAO, Y., Shanghai Yixue, 1996, 19 (10), 570–572.
  • Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B. SAMPAIO, R. N., and MARSDEN, P. D., Rev. Soc. Bras. Med. Trop., 1997, 30 (2), 125–128.
  • Tumor uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. VAAGE, J., DONOVAN, D., USTER, P., and WORKING, P., Br. J. Cancer, 1997, 75 (4), 482–486.
  • Ultrasonic visualization of still and flowing waters using contrast agents of magnetite-encapsulated porous silica microspheres. ZHANG, M., ITOH, T., and ABE, M., Jpn. J. Appl. Phys., Part I, 1997, 36 (1A), 243–246.
  • Ultrasound-enhanced ferrite plating, a novel technique applied to ferrite-encapsulation of polymer microspheres. ZHANG, M., KITAMOTO, Y HAIJIMA, S., MATSUMOTO, K., and ABE, M., Nippon Oyojiki Gakkaishi, 1997, 21(3), 135–138.
  • Unusual behavior of ion transport mediated by polyene antibiotics. Activation energies for the exchange of Na + ions through liposomal membranes studied by 23Na-NMR spectroscopy. KIMURA, A., KUNI, N., and FUJIWARA, H., Chem. Pharm. Bull., 1997, 45 (3), 431–436.
  • Use of receptors immobilized on microspheres to identify ligand binding sites in tissue sections: detection of lymph node ligands for L-Selectin. HUANG, X., and MARKS, R. M., Historhem. Cell Biol., 1997, 107 (1), 57–64.
  • Viscosity transitions in aqueous suspension of hydrogen microspheres. HOOPER, H. H., Yu, J., SASSI, A. P., and SOANE, D. S., y. Appl. Polym. Sri., 1997, 63 (10), 1369–1372.
  • Visualized dynamics of microtubules and liposomes. KANEKO, T., TANAKA, V., and HOTANI, H., Tanpakushitsu Kakusan Koso, 1997, 42 (7), 1215–1220.
  • Wound infiltration with liposomal bupivacaine prolongs analgesia in rats. GRANT, G. J., LAX, J., SUSSER, L., ZAKOWSKI, M., WEISSMAN, T. E., and TuaNnoaF, H., Acta. Anaesthesiol. Scand., 1997, 41(2), 204–207.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.